Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

LON/0ACX stock hub

LON/0ACX has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0ACXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

4.5B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0ACX

In the news

Latest news · LON/0ACX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-57.4

P25 n/aP50 n/aP75 n/a

ROIC-28.9

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0ACX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

140

Groups with data

Currency

USD

Showing 140 of 140 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United Kingdom
Country code	UK
Employees	118
Employees Change	41%
Employees Change Percent	53.25
Enterprise value	$4.4B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Isin	US1523091007
Last refreshed	2026-05-10
Market cap	$4.5B
Price	$39.59
Price currency	USD
Sic	2836
Symbol	lon/0ACX
Website	https://centessa.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-4.22%
EV Earnings	-23.07x
EV/FCF	-27.64x
FCF yield	-3.52%
P/B ratio	12.18x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-189.8M
Profit Per Employee	$-1.6M
ROA	-27.43
Roa5y	-25.12
ROCE	-42.41
ROE	-57.38
Roe5y	-75.18
ROIC	-28.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	222%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$486M
Cash	$209.5M
Current Assets	$255.8M
Current Liabilities	$26.8M
Debt	$89.2M
Debt Equity	$0.24
Debt FCF	$-0.56
Equity	$369.1M
Interest Coverage	-22.69
Liabilities	$116.9M
Long Term Assets	$230.2M
Long Term Liabilities	$90.1M
Net Cash	$120.2M
Net Cash By Market Cap	$2.67
Net Cash Growth	-4.64%
Net Debt Equity	$-0.33
Tangible Book Value	$369.1M
Tangible Book Value Per Share	$2.39
WACC	11.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.53
Net Working Capital	$26.9M
Quick ratio	9.11
Working Capital	$236.4M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-14.73%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	221.74%
200-day SMA	25.27
50-day SMA	33.67
50-day SMA vs 200-day SMA	50over200
All Time High	41.8
All Time High Change	-5.3%
All Time High Date	2026-03-31
All Time Low	8.49
All Time Low Change	366.25%
All Time Low Date	2024-07-05
ATR	0.53
Beta	1.26
Ch YTD	57.33
High	40
High52	41.8
High52 Date	2026-03-31
High52ch	-5.3%
Low	39.59
Low52	10.98
Low52 Date	2025-06-05
Low52ch	260.49%
Ma50ch	17.59%
Price vs 200-day SMA	56.62%
RSI	70.03
RSI Monthly	79.79
RSI Weekly	76.08
Sharpe ratio	1.4x
Sortino ratio	2.87
Total Return	-14.73%
Tr YTD	57.33
Tr1m	0.26%
Tr1w	0.26%
Tr3m	67.6%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-194.4M

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	97,983,692%
Shares Insiders	0.64%
Shares Institutions	55.72%
Shares Qo Q	8.15%
Shares Yo Y	14.73%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-183.9M
Average Volume	1,434.55x
Bv Per Share	2.39
CAPEX	$-280,960
Ch1m	0.26
Ch1w	0.26
Ch1y	221.8
Ch3m	67.6
Ch6m	80.47
Change	-0.02%
Change From Open	-1.04
Close	39.59
Days Gap	1.03
Depreciation Amortization	251,595.3
Dollar Volume	4,156.4
Earnings Date	2026-08-04
EBIT	$-194.4M
EBITDA	$-194.1M
EPS	$-1.35
F Score	1
FCF	$-158.4M
FCF EV Yield	-3.62x
Financing CF	241,511,380
Fiscal Year End	December
Founded	2,020
Income Tax	$963,292
Investing CF	-116,197,850
Is Primary Listing	0
Last Earnings Date	2025-11-12
Last Report Date	2026-03-31
Ma150	27.79
Ma150ch	42.42%
Ma20	39.54
Ma20ch	0.1%
Net CF	-31,860,579
Next Earnings Date	2026-08-04
Open	40
Position In Range	0
Ppne	7,713,633.2
Price Date	2026-05-08
Ptbv Ratio	12.18
Relative Volume	0.07x
Share Based Comp	25,478,769
Tr6m	80.47%
Volume	105

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does LON/0ACX pay a dividend?

Capital-return profile for this ticker.

Performance

LON/0ACX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0ACX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+55.7%

Share of float held by funds and institutions

Insider ownership

+0.6%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+14.7%

Negative means the company is buying back shares.

Technical

LON/0ACX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

70.0

Above 70: short-term overbought

Price vs 200-day MA

+56.6%

50/200-day relationship not available

Beta (5Y)

1.26

More volatile than the market

Sharpe ratio

1.40

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0ACX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0ACX stock rating?

lon/0ACX is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0ACX analysis?

The full report lives at /stocks/lon/0ACX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0ACX?

The latest report frames lon/0ACX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0ACX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.